Subtle Medical
Series B in 2024
Subtle Medical is a healthcare technology company that develops artificial‑intelligence software for magnetic resonance and positron emission tomography imaging. Its flagship products, SubtleMR and SubtlePET, are FDA‑cleared and CE‑marked tools that enhance image quality by reducing noise and sharpening detail, allowing scans to be performed faster and with lower radiation or contrast dose. The company’s deep‑learning algorithms integrate with any scanner without changing existing workflows, enabling imaging centers and hospitals to increase throughput and improve patient safety. Subtle Medical also offers a vendor‑agnostic AI platform that delivers analytics and support to clinical imaging providers. Founded in 2017 and headquartered in Menlo Park, California, the firm has received an NIH SBIR grant and an RSNA award for its GAD technology.
Aniai specializes in developing AI-powered robotic kitchen solutions aimed at enhancing efficiency in quick-service restaurants. Their flagship product is a double-sided grill capable of cooking up to eight patties simultaneously. It has garnered recognition and has secured funding to expand its manufacturing capabilities and market presence.
ImpriMed, Inc. is a biotechnology company focused on providing personalized drug response prediction services for veterinary oncology. Established in 2017 and headquartered in Palo Alto, California, with an additional office in Seoul, South Korea, the company specializes in analyzing the drug responses of live cancer cells from pets, particularly in cases of lymphoma. By collecting genetic and cellular information from these cancer cells, ImpriMed develops precision medicine techniques that assist veterinary oncologists in selecting the most effective anticancer treatments for individual pets. This patient-derived database not only enhances treatment decisions for animals but also has the potential to translate insights into human oncology, ultimately aiding in the development of tailored cancer therapies for humans.
Genome Insight
Series B in 2023
Genome Insight is a developer of a genome sequence (WGS) analysis and interpretation platform. Its platform offers insights through the precise interpretation of full-length genome big data to help clients employ the information effectively in their operations.
B Garage specializes in developing safety modules for autonomous drones, focusing on collision prevention and evasion technologies. Headquartered in the United States, the company aims to provide cost-effective inventory management solutions for warehouses using its advanced drone platform.
Earable Neuroscience
Convertible Note in 2023
Earable Neuroscience is a deep tech company focusing on building consumer wearables and solutions that unlock human potential through improved sleep and cognitive function. Earable was early-invested in by FoundersFund and Samsung Ventures. After 9 years of R&D at the University of Colorado and the University of Oxford, Earable invented FRENZ Brainband - a pioneering AI-powered sleep-aid wearable designed to track and stimulate brain activity in real time using science-backed personalized audio delivered via bone-conduction speakers.
VERTICAH
Seed Round in 2022
VERTICAH is a growth platform for startups offering alternative financing, venture capital, and asset management services. It operates a capital-raising platform that helps startups access funds by aligning financing with anticipated future sales, enabling growth while minimizing equity dilution through data-driven connections between companies and capital providers.
Silicon Box
Seed Round in 2021
Silicon Box specializes in advanced semiconductor packaging services. It offers full execution capabilities from initial design to final manufacturing of standard single chip packages, as well as sophisticated chiplet-based systems. The company's expertise enables applications such as AI, HPC, EV, automotive, power management, mobile chipsets, and more.